Given that the EPR effect in human melanoma is neither consistent nor sufficient for effective passive accumulation, on what scientific basis do you claim that liposomes, polymeric nanoparticles, and micelles can achieve “selective drug accumulation” and “reduced systemic toxicity” through passive targeting alone?